Atlas Trials

Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects

Clinical trial NCT01203384 · COMPLETED

Trial details

NCT number
NCT01203384
Sponsor
CERESPIR
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2010-09-01
Primary completion
2010-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.